版本:
中国

BRIEF-Phaserx reports Q1 loss per share $0.35

May 12 Phaserx Inc:

* Phaserx reports first quarter 2017 financial results and provides corporate update

* Q1 loss per share $0.35

* Phaserx Inc - as of March 31, 2017, company had cash, cash equivalents, and marketable securities of $11.9 million

* Phaserx - revising timeline for submission of IND for PRX-OTC to 2018, expect to generate clinical efficacy data in affected patients in H2 of 2018 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐